euqate nicotine
NDC 79903-101, Nicotine Polacrilex, lozenge, from WALMART INC..
- Product NDC
- 79903-101
- Status
- Listed
- Labeler
- WALMART INC.
- Dosage form
- LOZENGE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA077007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/79903-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NICOTINE2 mg/1
Pharmacologic classes
Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 79903-101-20 | 79903010120 | 1 CONTAINER in 1 CARTON (79903-101-20) / 20 LOZENGE in 1 CONTAINER |
| 79903-101-40 | 79903010140 | 40 LOZENGE in 1 CONTAINER (79903-101-40) |
| 79903-101-80 | 79903010180 | 2 CONTAINER in 1 CARTON (79903-101-80) / 40 LOZENGE in 1 CONTAINER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 79903-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/79903-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 79903-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.